| 000 | 01352 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250513130406.0 | ||
| 264 | 0 | _c19971126 | |
| 008 | 199711s 0 0 eng d | ||
| 022 | _a1352-4585 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSandberg-Wollheim, M | |
| 245 | 0 | 0 |
_aRecombinant human interferon beta in the treatment of relapsing-remitting and secondary progressive multiple sclerosis. _h[electronic resource] |
| 260 |
_bMultiple sclerosis (Houndmills, Basingstoke, England) _c1995 |
||
| 300 |
_aS48-50 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAdjuvants, Immunologic _xtherapeutic use |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aClinical Trials, Phase III as Topic |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterferon-beta _xtherapeutic use |
| 650 | 0 | 4 | _aMagnetic Resonance Imaging |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMulticenter Studies as Topic |
| 650 | 0 | 4 |
_aMultiple Sclerosis _xdiagnosis |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 |
_aRecombinant Proteins _xtherapeutic use |
| 650 | 0 | 4 | _aRecurrence |
| 700 | 1 | _aHommes, O R | |
| 700 | 1 | _aHughes, R A | |
| 700 | 1 | _aPaty, D W | |
| 700 | 1 | _aAbdul-Ahad, A K | |
| 773 | 0 |
_tMultiple sclerosis (Houndmills, Basingstoke, England) _gvol. 1 Suppl 1 _gp. S48-50 |
|
| 999 |
_c9316373 _d9316373 |
||